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ABSTRACT
Objective: To identify in the scientific literature, between 2016 and 2018, studies on polypharmacy in 
community-dwelling elderly. Methods: integrative review, performed in the PUBMED, BVS/BIREME, 
SCOPUS, WEB OF SCIENSE, EMBASE, Cochrane Library and CINAHL databases. Results: sixteen articles 
were selected for this review. Regarding the use of medication by elderly residents in the community, studies 
showed the prevalence of use, characteristics and factors associated with polypharmacy in the elderly; adequate 
knowledge of prescription drugs; and use of potentially inappropriate medications. Conclusion: identifying 
medication use in the elderly points to the need for better communication between professionals and patients, 
encouraging self-care, minimizing the risk of complications, preventing iatrogenesis and hospitalizations, as 
well as reducing mortality in the elderly due to improper medication use.
Descriptors:  Aged, Aging, Polypharmacy, Chronic disease, Health of the elderly.
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RESUMO
Objetivo: Identificar na literatura científica, entre os anos de 2016 e 
2018, estudos sobre a polifarmácia em idosos residentes na comunidade. 
Métodos: revisão integrativa, realizada nas bases de dados PUBMED, 
BVS/BIREME, SCOPUS, WEB OF SCIENSE, EMBASE, Cochrane Library 
e CINAHL. Resultados: dezesseis artigos foram selecionados para esta 
revisão. Quanto ao do uso de medicamentos por idosos residentes na 
comunidade, os estudos apresentaram a prevalência de uso, características 
e fatores associados à polifarmácia nos idosos; conhecimento adequado 
dos medicamentos prescritos; e uso dos medicamentos potencialmente 
inapropriados. Conclusão: a identificação do uso de medicamentos nos 
idosos aponta para a necessidade de melhor comunicação entre profissionais 
e pacientes, incentivar o autocuidado, minimizar o risco de complicações, 
prevenir iatrogenias e hospitalizações, assim como, reduzir a mortalidade 
em idosos por uso impróprio de medicamentos.. 
Descritores: Idoso, Envelhecimento, Polimedicação, Doença crônica, 
Saúde do idoso.
RESUMEN
Objetivo: Identificar en la literatura científica, entre 2016 y 2018, estudios 
sobre polifarmacia en personas mayores que viven en la comunidad. 
Metódos: revisión integral, realizada en las bases de datos PUBMED, BVS/
BIREME, SCOPUS, WEB OF SCIENSE, EMBASE, Biblioteca Cochrane 
y CINAHL. Resultados: se seleccionaron 16 artículos para esta revisión. 
Con respecto al uso de medicamentos por parte de los residentes de edad 
avanzada en la comunidad, los estudios mostraron la prevalencia del 
uso, las características y los factores asociados con la polifarmacia en los 
ancianos; conocimiento adecuado de medicamentos recetados; y el uso 
de medicamentos potencialmente inapropiados. Conclusión: identificar 
el uso de medicamentos en los ancianos señala la necesidad de una mejor 
comunicación entre profesionales y pacientes, fomentando el autocuidado, 
minimizando el riesgo de complicaciones, previniendo iatrogénicos y 
hospitalizaciones, así como reduciendo la mortalidad en los ancianos debido 
al uso inadecuado de medicamentos.
Descriptores: Anciano, Envejecimiento, Polifarmaci, Enfermedad crónica, 
Salud del anciano.
INTRODUCTION
For humanity, the greatest longevity can be considered 
a success story. 1 In Brazil, the population growth of the 
elderly population is on the rise, it is estimated that by 
2075 the peak population will be 79.2 million with ≥ 60 
years of age. However, the increase in life span, the greatest 
conquest of the 20th century, has become a great challenge 
for the current century. 2 Currently the profile of morbidity 
and mortality in the country has changed due to the rapid 
aging of the Brazilian population, with a decrease in acute 
conditions of short duration, such as infectious diseases 
and external causes, but with an increase in the frequency 
of chronic non-communicable diseases. 3 Therefore, 
concomitant to the advance of age occurs the increase of the 
incidence of chronic diseases and health problems, 4-5 with 
greater consumption of medicines for their treatment and 
consequent polypharmacy (use of five or more medicines 
simultaneously). 6-7 
Although there is no universally accepted definition 
for polypharmacy, most national and international studies 
consider the use of five or more drugs. 8-9
Many elderly people use medicines continuously, the 
average being observed in Brazilians, from 2 to 5 drugs. 8,10-
12 The prevalence of polypharmacy varies from 5 to 32%, 
according to data from national studies. 8,10,12 With the 
increase of life expectancy, it is necessary to know better 
the profile of the polypharmacy in elderly people in this 
age group. Facing this scenario, we consider it important 
to promote the discussion about the use of drugs in the 
elderly in the world and, for this, we propose an integrative 
review guided by the following question: What knowledge 
is produced about polypharmacy in elderly residents in the 
community, between the years 2016 and 2018?
Therefore, this study aims to identify in the scientific 
literature, between the years 2016 and 2018, studies on 
polypharmacy in elderly residents of the community.
 
METHODS
The present study used the integrative type bibliographic 
review method, which allows the search, critical analysis 
and synthesis of available evidence on the subject, allowing 
the identification of gaps that direct future research on 
the subject based on practice in evidence, 13 and follows a 
standard of excellence in methodological rigor. 14 
For the operationalization of this revision, we use the 
Endnote program to manage the bibliographic references 
and select the studies, as explained below. The following 
steps were used for the identification, selection, eligibility 
and inclusion of studies in the review: selection of the 
thematic issue; definition of the databases and descriptors; 
establishment of the criteria for inclusion and exclusion 
of publications to define the sample; determination of the 
information taken from the articles, analysis and evaluation 
of the works selected in the review and interpretation of the 
results. 15 
The search in literature was carried out through the 
survey of scientific productions carried out in November 
2018, in the main databases in the health area: PUBMED/
MEDLINE (National Library of Medicine and National 
Institutes of Health), Portal Biblioteca Virtual em Saúde 
(BVS)/BIREME, SCOPUS (Scopus Info Site), WEB OF 
SCIENSE, EMBASE, Cochrane Library and Cumulative 
Index to Nursing and Allied Health Literature (CINAHL). 
The period from 2016 to 2018 was delimited as a time 
clipping.
The following criteria were used to compose the sample: 
• Inclusion criteria: articles in English, Portuguese 
and Spanish; published in scientific journals from 2016 to 
2018 and with relevance and adherence to the proposed 
objective.
• Exclusion criteria: duplicate articles; bibliographical 
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review articles of any modality; end-of-course papers, 
dissertations and theses; and abstracts published in event 
annals. 
The search was performed by means of controlled 
descriptors, present in the Descritores em Ciência da 
Saúde (DeCS) and Medical Subject Headings (MESH), 
keywords and synonyms: “Aged, 80 and over”; “Aged”; 
“Polypharmacy”; “Health Status”, and Boolean operators 
for the crossover in the database.
As a method of analysis, the publications were initially 
read in full and the results were analyzed and described 
in types of studies on polypharmacy in the elderly in the 
chosen period. They were also organized and presented 
according to the descriptors and the database, description 
of the articles according to the variables surveyed (author, 
year of publication, country, journal, sampling, objective 
of the study and main results), and organization of the 
identified themes. The critical analysis and qualitative 
synthesis of the selected studies were performed in a 
descriptive manner.
RESULTS AND DISCUSSION
After the bibliographic search, 1,087 studies were 
identified (Chart 1). Then, the inclusion and exclusion 
criteria were analyzed and finally, only studies with elderly 
residents in the community were selected, resulting in 
16 studies in qualitative synthesis. The flowchart of the 
selection process of the articles is represented in Figure 1.
Table 1- Descriptors used for literature search in the main databases and 
number of  studies identified (n = 1,087). Campinas, SP, Brazil, 2018.
Figure 1- Flowchart for selection of  the studies found. Campinas, SP, 
Brazil, 2018.
Of the 16 articles in English considered, in relation to 
the year of publication, three (18.7%) were published in 
2016; eight (50%) in 2017, and six (37.5%) in 2018. 
Brazil stood out as the country with the highest 
number of publications on the subject, corresponding to 
four (25%), Spain and Malaysia both with two (12.5%) 
each. Also included were articles from other countries 
such as Italy, Israel, Austria, Germany, the Netherlands, 
the United States, European countries, New Zealand 
which corresponded to one (6.25%) each. The articles were 
published in 14 journals, highlighting the Revista de Saúde 
Pública and Plos One with two articles in each journal, 
respectively.
The description of the articles published in the literature, 
according to the variables (author, year of publication, 
country, journal, sample and objective of the study) 
researched in the period from 2016 to 2018 is presented 
in Chart 2.
Table 2- Description of  the articles published in the literature, according 
to the variables surveyed in the period from 2016 to 2018. Campinas, SP, 
Brazil, 2018.
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Regarding the use of drugs by elderly residents in the 
community, in the articles considered in this review the 
studies presented the prevalence of use, characteristics 
and factors associated with polypharmacy in the elderly; 
adequate knowledge of the drugs prescribed; and use of 
Potentially Inappropriate Drugs (PID). 
PREVALENCE OF DRUG USE, CHARACTERISTICS AND 
FACTORS ASSOCIATED WITH POLYPHARMACY IN 
THE ELDERLY 
The results showed that, as a consequence of population 
aging, the profile of elderly people who use drugs has 
been changing, since the prevalence of use in the more 
advanced age group is increasing. In the analysis of the 
articles of this study, a survey analyzed the percentage 
of polypharmacy in the elderly with age ≥ 65 years and 
evaluated differences between several countries, with 
variation of 26.3% to 39.9%. Among them, Switzerland, 
Croatia and Slovenia were the countries with the lowest 
prevalence of polypharmacy, while Portugal, Israel and the 
Czech Republic were the countries where the prevalence 
of polypharmacy was the highest. 23 The predominance of 
concomitant use of five or more drugs was 36.0% in the 
municipality of São Paulo (SP), according to the Estudo 
Saúde, bem-estar e envelhecimento (SABE)12 and 39.0% 
in the United States, in participants of the National Health 
and Nutrition Examination Survey.31  Comparisons should 
be made with caution due to the differentials of access to 
medicines in the different locations. 
In this review, national surveys that used the age 
bracket of 60 years or more detected prevalence of 32% in 
Florianopolis (SC)30 and 18.1% in the Pesquisa Nacional 
de Acesso, Utilização e Promoção do Uso Racional de 
Medicamentos (PNAUM); 26 other studies verified 10.3% 
in Cuiabá (MG)7 and 28.0% in Goiânia (GO). 32 
Some studies did not observe differences in the 
proportion of use of five or more drugs (polypharmacy) 
according to sex, 18.25.30 contradicting the results of other 
surveys. 20.29 Considering the age group ≥ 65 years old, 
women presented ratios of chances of polypharmacy of 
1.80 (95%CI: 1.20-2.60) in the municipality of São Paulo 
(SP)12 and 1.28 (95%CI: 1.27-1.29) in Sweden. 33 In Brazil, 
PNAUM found a higher prevalence of polymedication in 
women (20.1%; 95%CI: 18.4-21.9) than in men (15.6%; 
95%CI: 13.8-17.5).8
There was also no difference in polypharmacy in relation 
to the age groups, 18.25 differently from what was observed 
in Florianopolis (SC) with a sample of 1,705 elderly people, 
who found an increase in the prevalence of polypharmacy 
with age (38.0% higher in those aged 80 or older, compared 
to those aged 60 to 69). 30 A three-year follow-up study in 
Sweden, with more than 1.7 million elderly (age ≥ 65 years) 
found prevalence of polypharmacy at 53.0% (75-84 years), 
65.5% (85-94 years), and 67.0% (≥ 95 years), with reference 
to the segment of 65-74 years (32.8%).33 
In this review, a cross-sectional study conducted in 
European countries (n=3,904 elderly people aged ≥ 75 
years) identified a higher risk of hyperpolypharmacy (≥ 10 
drugs) in individuals with multi-morbidity and obese. 30 
Some authors point out that the practice of 
polymedication increases with the number of chronic 
diseases. 8.32 In Swedish elderly (≥ 65 years), there was 
an intense increase in polypharmacy with the number of 
chronic diseases, rising from 28.6% in those who reported 
one to 45.4% and 59.9% in those who reported two and 
three diseases, respectively, reaching 87.2% among those 
who had five or more diseases. 33  
We verified greater consumption of drugs among the 
obese elderly, 30 because it can result from comorbidities 
and metabolic alterations associated to these conditions, 
besides changes caused by body fat in the absorption, 
distribution and metabolization of drugs.34 In Goiânia 
(GO), a study identified in the bivariate analysis, a higher 
prevalence of polymedication in those with very increased 
waist circumference (34.6%), whereas in the hierarchical 
model, polymedication proved to be superior among the 
obese (RP=2.41; 95%CI: 1.24-4.70 compared to low weight. 
32 
ADEQUATE KNOWLEDGE OF PRESCRIBED DRUGS 
A study conducted in the primary care of the Netherlands 
on the adequate knowledge of the indications for 
prescribed drugs among elderly patients in the community 
with polypharmacy revealed that few patients were able to 
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correctly inform the indications for all prescribed drugs 
in use. Among the factors associated with the deficit of 
knowledge about drugs were the high consumption of 
drugs, male gender and age over 80 years. 16
However, in another study conducted with elderly (≥ 
65 years) living in the community in Canada, the correct 
knowledge of the general purpose of the use of prescribed 
and non-prescribed drugs was assessed, and most elderly 
people reported good knowledge about the purpose of the 
drugs used. 35
In a study conducted in Serbia in 2014 on the needs 
and concerns of patients using polypharmacy, patients 
with diabetes showed a better understanding of the use of 
drugs, but those who used prolonged action nitrates had 
difficulty in understanding the reason for the use of these 
medications.  Of the 440 elderly interviewees who used five 
or more medications simultaneously, 5.2% were not aware 
of the indication of the prescribed drugs. 36
USE OF POTENTIALLY INAPPROPRIATE DRUGS (PID) 
The use of PID is related to the occurrence of Adverse 
Drug Reactions (ADRs), being an important public health 
problem for the elderly population, besides being associated 
to the risk of hospitalization and mortality. 37 
ADRs can be avoided by preventing the use of PID 
and undesirable combinations. 38 Therefore, it is necessary 
to be clear about the factors that affect the elderly 
population, such as the frequent and simultaneous use of 
several medications39 and the risk of toxicity caused by the 
medications due to physiological alterations of the aging 
process. 40 
Prescribing PID to the elderly may cause actual or 
potential harm instead of therapeutic benefits. In several 
countries, to avoid the use of PID, instruments were adopted 
to detect its use and these were essential to optimize the 
drug prescription, as well as minimize the negative effects 
of pharmacotherapy in this population. 41
Primary care aims at the treatment of diseases and 
prevention of illness, but this often occurs only through the 
prescription of drugs in medical consultations. However, 
professionals need to be careful with improper prescriptions 
that culminate in polypharmacy and its complications. The 
treatment of various health problems in the elderly can be 
enhanced through changes in lifestyle. 41,42 
There are instruments that assess the appropriateness 
of prescription in the elderly based on the verification of a 
list of drugs considered potentially inappropriate in specific 
conditions or situations. 43 In the United States, the most 
frequently cited and used list of PIDs for seniors are the 
Beers Criteria, and in Ireland, the Screening Tool of Older 
Persons’ Potentially Inappropriate Prescriptions (STOPP). 
44
The prevalence of MPI in seniors was verified by the 
American Geriatrics Society’s Beers Criteria (2012/2015) 
studying 70,479 seniors (≥ 65 years) and residents in the 
New Zealand community. The exposure to PID was higher 
in males, aged ≥ 95 years and in those using medications 
active in the gastrointestinal and central nervous system. 16
In the U.S., Beers (2012) criteria were applied to 
16,588 non-institutionalized seniors of age ≥ 65 and it 
was identified that almost one-third (30.9%) of older 
adults used an PID; the association of PID use with poor 
health conditions was observed. The lower use of PID was 
associated with an increase in age and educational level; the 
study pointed to the need to address the risk conditions of 
MPI in educational programs directed to medical practice. 
24
CONCLUSIONS
The results obtained in this review made it possible to 
identify what has been addressed in publications regarding 
the use of drugs by elderly residents in the community. 
The importance of characterizing the profile of the elderly 
and the prevalence of polypharmacy is highlighted, as well 
as understanding the indiscriminate use of potentially 
inappropriate drugs and the lack of knowledge of the 
drug indications prescribed to the elderly. Studies on drug 
interactions in polymedicated elderly are less frequent in 
the literature, denoting the importance of expanding the 
scope of investigation on the use of drugs in community 
elderly.
Some recommendations are made in the studies 
addressed, such as improving communication between 
professionals and patients and the importance of knowledge 
about medications by patients, in order to encourage self-
care and ensure adherence to treatment, minimizing the risk 
of complications, in addition to preventing iatrogenicity, 
hospitalization and reducing mortality in the elderly due to 
misuse of medication.
Consequently, the challenges of Brazilian health services 
in the area of geriatrics and gerontology necessarily include 
ensuring policies that promote quality of life in the aging 
process of the elderly in the country.
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